MSCT boosts diagnosis of perforated appendicitis

Article

Japanese researchers have found the detection of an enhancement defect of the appendiceal wall using multislice CT allows accurate diagnosis of perforations of the inflamed appendix.

Japanese researchers have found the detection of an enhancement defect of the appendiceal wall using multislice CT allows accurate diagnosis of perforations of the inflamed appendix.

CT has proved its worth in the management of appendicitis. Studies of appendiceal perforation using CT are infrequent, however, and restricted to single-slice scanners. The use of contrast-enhanced multislice CT for imaging of the appendiceal wall is a highly accurate technique for the detection of these lesions, according to the investigative team led by Dr. Masahiro Tsuboi, a radiologist at the Tohoku University Graduate School of Medicine in Miyagi.

Tsuboi and colleagues retrospectively evaluated 102 patients with confirmed appendicitis between January 2000 and December 2002 who underwent IV contrast-enhanced CT scanning on a four-slice unit. Two independent observers evaluated five specific findings: appendiceal wall enhancement, abscess, phlegmon, extraluminal air, and extraluminal appendicolith. They recorded the sensitivity, specificity, and accuracy of the specific findings in the diagnosis of perforated appendicitis.

The investigators found that MSCT was able to spot appendix perforations accurately in more than 96% of cases based on a particular enhancement defect of the appendiceal wall. They published their results in the January issue of Radiology (2008;246:142-147).

Contrast-enhanced MSCT confirmed a perforated appendicitis in 40 patients, 38 of whom showed an enhancement defect of the appendiceal wall. The sensitivity, specificity, and accuracy values associated with this finding in the diagnosis of perforation were 95%, 96.8%, and 96.1%, respectively.

Although abscesses, extraluminal air, and extraluminal appendicolith did not appear in patients with nonperforated appendicitis, their sensitivities for perforation as shown by CT were only 37.5%, 22.5%, and 32.5%, respectively. Three patients in the nonperforated group and 16 in the perforated group had signs of phlegmon on MSCT. The sensitivity, specificity, and accuracy values of phlegmon in the diagnosis of perforation were 40.0%, 95.2%, and 73.5%, respectively.

The study had limitations, though. Laparoscopic or open surgery could have produced minor injuries that were later erroneously interpreted as perforation. Some sites with perforation may have been missed. And some perforations could have occurred during the 24 hours between CT scanning and surgery.

The use of the cine mode display of transverse thin sections during contrast-enhanced CT scanning, however, consistently depicted a defect that can accurately differentiate perforated and nonperforated appendicitis, the researchers said.

For more information from the Diagnostic Imaging archives:

Low-dose MSCT spots renal calculi safely, accurately in overweight patients

MSCT enterography rapidly emerges as first-line exam

CT, ultrasound may save women from appendectomy

Axial images give way to coronal reformats in abdomen

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.